Go Pro

DLH (NASDAQ:DLHC) Raised to Hold at Zacks Research

DLH logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research upgraded DLH from “strong sell” to “hold,” bringing the consensus rating to “Hold” alongside one Buy and one Sell rating from other analysts.
  • DLH reported a significant quarterly loss, with EPS of -$1.16 versus the consensus estimate of -$0.17, while revenue of $44.23 million fell short of expectations.
  • The stock opened at $3.70, near its 52-week low of $3.38, and has declined below its 50-day and 200-day moving averages; insiders have continued buying shares, including a 7,944-share purchase by major shareholder Mink Brook Asset Management.
  • Five stocks we like better than DLH.

DLH (NASDAQ:DLHC - Get Free Report) was upgraded by stock analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a report issued on Tuesday, Zacks reports.

DLHC has been the topic of several other reports. Weiss Ratings reissued a "sell (d)" rating on shares of DLH in a research note on Friday, July 17th. Noble Financial reaffirmed an "outperform" rating on shares of DLH in a research note on Friday, July 31st. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, DLH currently has a consensus rating of "Hold".

Read Our Latest Research Report on DLH

DLH Stock Performance

Shares of NASDAQ:DLHC opened at $3.70 on Tuesday. The firm has a fifty day simple moving average of $4.38 and a two-hundred day simple moving average of $5.19. DLH has a 52 week low of $3.38 and a 52 week high of $8.10. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.13. The stock has a market capitalization of $53.61 million, a P/E ratio of -2.50 and a beta of 1.44.

DLH (NASDAQ:DLHC - Get Free Report) last announced its earnings results on Wednesday, July 29th. The business services provider reported ($1.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.99). DLH had a negative net margin of 8.51% and a negative return on equity of 10.42%. The business had revenue of $44.23 million for the quarter, compared to analysts' expectations of $50.00 million. On average, analysts expect that DLH will post -0.76 earnings per share for the current fiscal year.

Insider Transactions at DLH

In other DLH news, major shareholder Mink Brook Asset Management Ll bought 7,944 shares of the company's stock in a transaction on Thursday, July 30th. The stock was acquired at an average price of $4.96 per share, for a total transaction of $39,402.24. Following the completion of the transaction, the insider directly owned 2,166,724 shares of the company's stock, valued at approximately $10,746,951.04. This represents a 0.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have bought a total of 53,986 shares of company stock valued at $263,214 over the last ninety days. 12.80% of the stock is owned by company insiders.

Institutional Investors Weigh In On DLH

A hedge fund recently bought a new position in DLH stock. Bank of New York Mellon Corp acquired a new stake in DLH Holdings Corp. (NASDAQ:DLHC - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 11,738 shares of the business services provider's stock, valued at approximately $62,000. Bank of New York Mellon Corp owned about 0.08% of DLH as of its most recent SEC filing. 67.25% of the stock is currently owned by institutional investors.

DLH Company Profile

(Get Free Report)

DLH Holdings Corp. NASDAQ: DLHC provides technology-enabled healthcare, human services, logistics and technical solutions primarily to agencies of the U.S. federal government. Its work supports public health, medical research, clinical care, military and veteran services, and government program operations.

The company's offerings include healthcare delivery and administration, data analytics, information technology and digital transformation, scientific and technical support, medical logistics, and program management.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DLH Right Now?

Before you consider DLH, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DLH wasn't on the list.

While DLH currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines